Litcius/Paper detail

Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Mariela Blum Murphy, Naruhiko Ikoma, Xuemei Wang, Jeannelyn S. Estrella, Sinchita Roy‐Chowdhuri, Prajnan Das, Bruce D. Minsky, Shumei Song, Paul Mansfield, Jaffer A. Ajani, Brian D. Badgwell

2020Annals of Surgical Oncology29 citationsDOI

Topics & Concepts

MedicineSurgical oncologyPaclitaxelMitomycin CCisplatinPeritoneal carcinomatosisOncologyAdenocarcinomaInternal medicineCytologyChemotherapyHyperthermic intraperitoneal chemotherapyGeneral surgeryCancerSurgeryCytoreductive surgeryPathologyOvarian cancerColorectal cancerIntraperitoneal and Appendiceal MalignanciesHepatocellular Carcinoma Treatment and PrognosisGastric Cancer Management and Outcomes
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology | Litcius